LifeStance director sells 69,899 LFST shares
LifeStance Health Group, Inc. director Robert Bessler reported open-market sales of LifeStance common stock through entities he is associated with.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. director Robert Bessler reported open-market sales of LifeStance common stock through entities he is associated with. On April 24, Shama LLC sold 31,074 shares and Vitthal LLC sold 31,073 shares at a reported price of $7.05 per share. On April 23, Shama LLC and Vitthal LLC each sold 3,876 shares at a reported price of $7.00 per share.
After these transactions, reported indirect holdings included 1,391,246 shares through Shama LLC, 1,274,448 shares through Vitthal LLC and 36,363 shares held of record by Alpine Glow Capital, plus 57,619 shares held directly. The footnotes state that Bessler disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 31,073 | $7.05 | $219K |
| Sale | Common Stock | 31,074 | $7.05 | $219K |
| Sale | Common Stock | 3,876 | $7.00 | $27K |
| Sale | Common Stock | 3,876 | $7.00 | $27K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.005 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose.
- F3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
- F4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.095 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Key Figures
Key Terms
open-market sale financial
weighted average price financial
beneficial ownership financial
pecuniary interest financial
Section 16 regulatory
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LifeStance (LFST) director Robert Bessler report in this Form 4?
What does the Form 4 disclose about Alpine Glow Capital’s LifeStance (LFST) holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.